1. Centre for Addiction and Mental Health. Opioid agonist therapy: a synthesis of Canadian guidelines for treating opioid use disorder. 2021.
2. Health and Human Services Department. Practice guidelines for the administration of buprenorphine for treating opioid use disorder. Fed Reg. 2021;86:22439–40.
3. Sordo L, Barrio G, Bravo MJ, Indave BI, Degenhardt L, Wiessing L, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:1550. https://doi.org/10.1136/bmj.j1550.
4. Health Canada. Surveillance of opioid- and stimulant-related harms in Canada. 2021.
5. Ahamad K, Kerr T, Nolan S, Wood E. Moving towards improved access for evidence-based opioid addiction care in British Columbia. 2016.